Tag: FDA Advocacy

FDA Comments- Makena

[FDA-2019-N-4203] To Whom It May Concern: The National Women’s Health Network (NWHN) is a nonprofit advocacy organization that works to improve the health of all women. We are supported by our members and by choice, we do not accept financial support from drug companies or medical device manufacturers. We bring the voices, concerns and needs of women consumers to policy and regulatory tables. The NWHN encourages the Food and Drug…

Read More

Fighting Fear With Facts: What to Know About the Public Charge Rule

Last month, the Trump administration finalized a radical new rule as part of their larger attack on immigrant communities. Known as the “public charge” rule, it’s a particularly cruel and short-sighted example of the administration’s on-going attempt to limit immigration of poor brown communities, primarily from Latin America (specifically Central America), as well as harm  immigrant communities already residing within the U.S.

Read More

Consumer Health Info: Addyi Health

Flibanserin (brand name: Addyi) is the first drug approved by the U.S. Food and Drug Administration (FDA) to treat lack of sexual desire (Hypoactive Sexual Desire Disorder) in premenopausal women.

Read More

Consumer Health Info: Vyleesi

Bremelanotide (brand name: Vyleesi) is a drug approved by the FDA to treat a lack of sexual desire (hypoactive sexual desire disorder) in premenopausal women.

Read More